1st Quarter - Report

COLLIER COLLECTIVE, LLC for DRUG POLICY ACTION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

1. Advocated for increased FY22 funding in the Labor, Health & Human Services, Education, and Related Agencies appropriations bill for HHS/CDC's Infectious Diseases & Opioid Epidemic program to expand access to overdose prevention and other harm reduction services to help prevent skyrocketing overdose deaths nationwide and prevent the transmission of infectious diseases. 2. Advocated on implementation of $30 million in funding to support overdose prevention, syringe services programs, and harm reduction services authorized and allocated by the American Rescue Plan Act.

LobbyistCovered position, as disclosed
JENNY COLLIER —
DANIELLE NEAL —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP)

Law Enforcement/Crime/Criminal Justice LAW

Advocated on the effectiveness of overdose prevention centers and the need for the Administration to permit and support this intervention in the U.S. to help save lives by reducing drug overdose deaths.

LobbyistCovered position, as disclosed
JENNY COLLIER —

Contacted: Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.